Peer-reviewed veterinary case report
How prostaglandin E2 affects immune response in dogs
By Venturin, Gabriela Lovizutto et al.·Published in Parasite immunology·2020·School of Veterinary Medicine (Faculdade de Medicina Veteriná, Brazil·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Regulatory effect of PGEon microbicidal activity and inflammatory cytokines in canine leishmaniasis.
- Species:
- dog
Plain-English summary
A study looked at how a substance called Prostaglandin E2 (PGE) affects dogs with leishmaniasis, a disease caused by a parasite. Researchers found that dogs with this condition had lower levels of certain receptors that respond to PGE compared to healthy dogs. When the immune cells from these sick dogs were treated with PGE, the levels of harmful cytokines decreased, and the number of parasites in the cells also dropped. This suggests that PGE might help boost the immune response in dogs suffering from leishmaniasis.
People also search for: dog leishmaniasis treatment · Prostaglandin E2 for dogs · canine leishmaniasis symptoms
Abstract
Canine leishmaniasis (CanL) is caused by the intracellular parasite Leishmania infantum. Prostaglandin E2 (PGE) exerts potent regulatory effects on the immune system in experimental model Leishmania infection, but this influence has not yet been studied in CanL. In this study, PGEand PGEreceptor levels and the regulatory effect of PGEon arginase activity, NO, IL-10, IL-17, IFN-γ, TNF-α and parasite load were evaluated in cultures of splenic leucocytes obtained from dogs with CanL in the presence of agonists and inhibitors. Our results showed that splenic leucocytes from dogs with CanL had lower EP2 receptor levels than those of splenic leucocytes from healthy animals. We observed that NOlevels decreased when the cells were treated with a PGEreceptor agonist (EP1/EP2/EP3) or COX-2 inhibitor (NS-398) and that TNF-α, IL-17 and IFN-γ cytokine levels decreased when the cells were treated with a PGEreceptor agonist (EP2) or PGEitself. The parasite load in splenic leucocyte cell cultures from dogs with CanL decreased after stimulation of the cells with PGE. We conclude that Leishmania infection of dogs modulates PGEreceptors and speculate that the binding of PGEto its receptors may activate the microbicidal capacity of cells.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32173875/